Acacia Pharma Ltd - Company Review
Acacia Pharma Ltd - Company ReviewSummary
Acacia Pharma Ltd (Acacia Pharma), a subsidiary of Acacia Pharma Group PLC is a developer and producer of new treatments for patients with cancer. The company’s products include supportive care products, post surgical products, cancer treatment products, and others. Its pipeline products comprise baremsis, APD403, APD515, and APD209. Acacia Pharma’s products are used in the treatment of cancer supportive care, post-operative nausea and vomiting, chemotherapy induced nausea and vomiting, xerostomia, and cancer cachexia. The company serves transforming medicine, advancing care, and pharmaceutical sectors. It also establishes licensing and distribution agreements with pharmaceutical partners outside the US. Acacia is headquartered in Cambridge, the UK.
This comprehensive company report of Acacia Pharma Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.